Willow Biosciences Inc. announced changes to its management team with the promotion of Dr. Chris Savile to Chief Operations Officer and the departure of Dr. Peter Facchini, Chief Scientific Officer, and Dr. Jill Hagel, Vice President, Applied Science, effective immediately. Dr. Chris Savile has been with Willow since April 2019 in the role of Vice President, Commercial Operations. Prior to joining Willow, Dr. Savile worked in senior leadership roles at Intrexon Corporation, a biotechnology company, and Codexis Inc., a protein engineering company. He is a highly experienced chemist, high throughput assay scientist and protein engineer with a strong technical background. Dr. Savile has been the research and development leader on several programs that led to commercial manufacturing processes. He received his PhD in 2006 from McGill University.